Top Markets
Coin of the day
Arch Therapeutics, Inc. Arch Therapeutics, Inc.

Arch Therapeutics, Inc.

ARTH
주식 순위 #42478
Arch Therapeutics, Inc., operating alongside its affiliated companies,... Arch Therapeutics, Inc., operating alongside its affiliated companies, functions as a biotechnology firm within the United States. The organization focuses on developing and commercializing products derived from its unique AC5 self-assembling technology platform. These innovations are engineered to arrest bleeding, control fluid leakage, and assist in wound care during surgical interventions, following trauma, throughout interventional medical procedures, or in cases of disease. Its leading products, the AC5 advanced wound system and the AC5 topical hemostat, are specifically designed for application on the skin, proving effective for managing intricate chronic wounds or acute surgical injuries. The company was established in 2006 and is headquartered in Framingham, Massachusetts.
주가
$0.0009
마지막 동기화: 2025-05-27
시가총액
$1.15K
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
US
거래 Arch Therapeutics, Inc. (ARTH)

카테고리

Arch Therapeutics, Inc. (ARTH)의 EPS
June 2024 기준 EPS TTM: $-2.86
Arch Therapeutics, Inc.의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 $-2.86입니다. 2022년 말에는 회사의 EPS가 $-3.56였으며, 이는 2021년의 EPS $-5.97와 감소입니다.
Arch Therapeutics, Inc.의 EPS 기록 (2011 ~ 2026)
매년 말의 EPS
연도 EPS 변화
2026 (TTM) $-2.86 25.99%
2023 $-2.27 -36.24%
2022 $-3.56 -40.37%
2021 $-5.97 39.81%
2020 $-4.27 30.58%
2019 $-3.27 -48.10%
2018 $-6.30 -42.25%
2017 $-10.91 10.54%
2016 $-9.87 36.33%
2015 $-7.24 -70.00%
2014 $-24.13 114.11%
2013 $-11.27 766.92%
2012 $-1.30 1,424.03%
2011 $-0.09 0.00%
유사 기업 또는 경쟁사의 EPS
회사 EPS EPS 차이 국가
$17.32 -705.59%
US
$27.74 -1,069.93%
NL
- -
CH
$13.70 -579.02%
BE
- -
KR